Business Description
Launxp Biomedical Co Ltd
ISIN : TW0006876006
Description
Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 61.54 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 12.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -9.8 | |||||
| 3-Year EPS without NRI Growth Rate | -8.8 | |||||
| 3-Year FCF Growth Rate | -2.1 | |||||
| 3-Year Book Growth Rate | 2.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.92 | |||||
| 9-Day RSI | 43.35 | |||||
| 14-Day RSI | 43.35 | |||||
| 3-1 Month Momentum % | -22.76 | |||||
| 6-1 Month Momentum % | 12.78 | |||||
| 12-1 Month Momentum % | -29.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.17 | |||||
| Quick Ratio | 11.17 | |||||
| Cash Ratio | 10.47 | |||||
| Days Sales Outstanding | 98.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -44 | |||||
| Shareholder Yield % | -25.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -3621.64 | |||||
| Net Margin % | -3612.47 | |||||
| FCF Margin % | -2789.74 | |||||
| ROE % | -64.23 | |||||
| ROA % | -58.02 | |||||
| ROIC % | -386.72 | |||||
| 3-Year ROIIC % | -466.16 | |||||
| ROC (Joel Greenblatt) % | -1230.74 | |||||
| ROCE % | -63.26 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 228.57 | |||||
| PB Ratio | 3.83 | |||||
| Price-to-Tangible-Book | 4.27 | |||||
| EV-to-EBIT | -4.89 | |||||
| EV-to-EBITDA | -5.03 | |||||
| EV-to-Revenue | 176.12 | |||||
| EV-to-FCF | -6.27 | |||||
| Price-to-Net-Current-Asset-Value | 4.4 | |||||
| Price-to-Net-Cash | 4.73 | |||||
| Earnings Yield (Greenblatt) % | -20.46 | |||||
| FCF Yield % | -12.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Launxp Biomedical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 2.495 | ||
| EPS (TTM) (NT$) | -3.28 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 44.8 | ||
| 14-Day RSI | 43.35 | ||
| 14-Day ATR (NT$) | 0.661818 | ||
| 20-Day SMA (NT$) | 17.6825 | ||
| 12-1 Month Momentum % | -29.12 | ||
| 52-Week Range (NT$) | 15 - 29.55 | ||
| Shares Outstanding (Mil) | 32.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Launxp Biomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Launxp Biomedical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Launxp Biomedical Co Ltd Frequently Asked Questions
What is Launxp Biomedical Co Ltd(ROCO:6876)'s stock price today?
The current price of ROCO:6876 is NT$17.60. The 52 week high of ROCO:6876 is NT$29.55 and 52 week low is NT$15.00.
When is next earnings date of Launxp Biomedical Co Ltd(ROCO:6876)?
The next earnings date of Launxp Biomedical Co Ltd(ROCO:6876) is .
Does Launxp Biomedical Co Ltd(ROCO:6876) pay dividends? If so, how much?
Launxp Biomedical Co Ltd(ROCO:6876) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers